IL13 and Alzheimer disease: AD is primarily driven by Th2-mediated immune responses, with cytokines such as IL-4, IL-13, and IL-31 playing pivotal roles in disrupting skin barrier function, promoting IgE production, and modulating inflammatory pathways (16–20).